<div id="readability-page-1"><p><span>Equifax (NYSE:EFX - Get Free Report)</span> had its price target reduced by equities research analysts at Morgan Stanley  from $290.00 to $280.00 in a research report issued on Wednesday, Marketbeat reports. The brokerage currently has an &#34;overweight&#34; rating on the credit services provider's stock. Morgan Stanley's price target suggests a potential upside of 27.64% from the stock's current price.</p><ul><li>FICO’s Big Dip Could Be the Best Buying Chance of the Year</li></ul><p>EFX has been the subject of several other reports. Stifel Nicolaus dropped their target price on shares of Equifax from $295.00 to $253.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, October 22nd. Seaport Res Ptn raised shares of Equifax to a &#34;hold&#34; rating in a research note on Wednesday, October 1st. UBS Group lifted their price objective on Equifax from $287.00 to $297.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, September 15th. Wells Fargo &amp; Company lowered their target price on Equifax from $300.00 to $285.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday, October 15th. Finally, Needham &amp; Company LLC  restated a &#34;buy&#34; rating and set a $295.00 price target on shares of Equifax in a research report on Tuesday, October 21st. One research analyst  has rated the stock with a Strong Buy rating, twelve have given a Buy rating and seven have assigned  a Hold rating to the stock. Based on data from MarketBeat, Equifax  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $274.73.</p><p><b>View Our Latest Stock Analysis on Equifax</b></p><h2>Equifax Trading Up 0.4%</h2><ul><li>3 Stocks Just Announced Intentions to Buyback Near 10% of Shares</li></ul><p>EFX traded up $0.84 during trading on Wednesday, hitting $219.37. 340,953 shares of the stock traded hands, compared to its average volume of 1,139,664. The firm has a market capitalization of $26.85 billion, a P/E ratio of 41.63, a price-to-earnings-growth ratio of 2.43 and a beta of 1.59. Equifax has a 12-month low of $199.98 and a 12-month high of $281.07. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.74 and a quick ratio of 0.74. The firm has a 50-day moving average of $216.53 and a 200 day moving average of $240.34. </p><p>Equifax (NYSE:EFX - Get Free Report) last posted its earnings results on Tuesday, October 21st. The credit services provider reported $2.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.10. Equifax had a return on equity of 19.28% and a net margin of 11.08%.The company had revenue of $1.54 billion for the quarter, compared to analysts' expectations of $1.52 billion. During the same period last year, the firm earned $1.85 earnings per share. Equifax's quarterly revenue was up 7.2% on a year-over-year basis. Equifax has set its Q4 2025 guidance at 1.980-2.080 EPS and its FY 2025 guidance at 7.550-7.650 EPS.  Equities research analysts anticipate that  Equifax will post 7.58 EPS for the current year. </p><h2>Insiders Place Their Bets</h2><ul><li>4 Undervalued Growth Stocks to Buy and Hold for the Long Term</li></ul><p>In other news, CEO Mark W. Begor sold 21,386 shares of the business's stock in a transaction on Monday, October 27th. The stock was sold at an average price of $231.12, for a total value of $4,942,732.32. Following the completion of the transaction, the chief executive officer owned 22,045 shares in the company, valued at $5,095,040.40. The trade was a 49.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, EVP Jamil Farshchi sold 4,925 shares of the stock in a transaction on Monday, October 27th. The shares were sold at an average price of $238.94, for a total value of $1,176,779.50. Following the sale, the executive vice president directly owned 39,364 shares in the company, valued at $9,405,634.16. This trade represents a 11.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 54,270 shares of company stock valued at $12,580,837. Corporate insiders own  1.40% of the company's stock. </p><h2>Institutional Inflows and Outflows</h2><p>A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Hudson Bay Capital Management LP bought a new stake in  Equifax in the 3rd quarter worth approximately $4,981,000.  Allworth Financial LP boosted its stake in shares of  Equifax by 6.9% in the 3rd quarter. Allworth Financial LP now owns 2,725 shares of the credit services provider's stock worth $699,000 after buying an additional 177 shares during the last quarter.  JPMorgan Chase &amp; Co. boosted its stake in shares of  Equifax by 27.1% in the 3rd quarter. JPMorgan Chase &amp; Co. now owns 767,982 shares of the credit services provider's stock worth $197,018,000 after buying an additional 163,866 shares during the last quarter.  CIBC Private Wealth Group LLC grew its holdings in shares of  Equifax by 61.6% in the third quarter. CIBC Private Wealth Group LLC now owns 4,453 shares of the credit services provider's stock worth $1,142,000 after acquiring an additional 1,698 shares during the period.  Finally, CIBC Bancorp USA Inc. purchased a new stake in  Equifax during the third quarter valued at $4,385,000. Institutional investors own  96.20% of the company's stock. </p><h2>About Equifax</h2> (Get Free Report)<p>Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.</p><h2>See Also</h2><ul><li>Five stocks we like better than Equifax</li><li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li><li>Massive Breakout in Industrials: 3 Must-Watch Stocks Now</li><li>Are Penny Stocks a Good Fit for Your Portfolio?</li><li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li><li>Basic Materials Stocks Investing</li><li>25 Years Later, Cisco Finally Recovers From the Dot-Com Crash</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVGWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVGWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Equifax Right Now?</h2><p>Before you consider Equifax, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.</p><p>While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Morgan Stanley has reduced its price target for Equifax from $290.00 to $280.00, maintaining an "overweight" rating. This suggests a potential upside of 27.64% from the current stock price. Other analysts have varied ratings, with a consensus of "Moderate Buy" and a target price of $274.73. Equifax's recent earnings exceeded expectations, and insider trading activity has been noted.</p>

Morgan Stanley Cuts Equifax (NYSE:EFX) Price Target to $280.00